Longer Treatment with Cancer Drug Following Removal of GI Tumor Results in Improved Survival
Tuesday, March 27, 2012 - 15:31
in Health & Medicine
Among patients with a high risk of recurrence of a gastrointestinal stromal tumor following surgery for its removal, patients who received imatinib (a drug to treat certain cancers) for 3 years instead of 1 had improved recurrence-free survival and overall survival, according to a study in the March 28 issue of JAMA.